Copley Scientific has announced the launch of a new inhaled dissolution dose collector (IDDC) system for the collection of representative samples of particles from MDIs and DPIs for dissolution testing by USP Method 2. The system can collect the impactor sized mass or the fine particle dose, depending on the inlet used. According to Copley, the IDDC works with … [Read more...] about Copley Scientific introduces new inhaled dissolution dose collector
Products and Services
Nanoform adds US subsidiary
Nanoform, a specialist in nanonization technology, has announced the establishment of a wholly owned US subsidiary, citing growing demand for its technology from US pharma companies. Nanoform recently announced the appointment of former Catalent executive Sally Langa as its new Head of US Sales. In November 2019, Nanoform won the 2019 Excellence in Pharma: … [Read more...] about Nanoform adds US subsidiary
Boehringer Ingelheim’s reusable Respimat SMI wins 2020 Pharmapack eco-design award
Boehringer Ingelheim's reusable Respimat soft mist inhaler has won the 2020 Pharmapack Eco-Design Award, the company said. As many as six medication cartridges can be used with this version of the Respimat before the device must be replaced, significantly reducing the amount of plastic waste. According to the company, the reusable Respimat is expected to save 776 … [Read more...] about Boehringer Ingelheim’s reusable Respimat SMI wins 2020 Pharmapack eco-design award
Nemera’s Safe’n’Spray wins Pharmapack 2020 innovation award
Drug delivery device maker Nemera said that its Safe’n’Spray concept intranasal device has won the "Best Innovation In Drug Delivery Device" Award at Pharmapack. In addition to being a connected device that allows for usage monitoring and analysis, the Safe’n’Spray utilizes electronic fingerprint identification and locking to control dosing of potent drugs, with the … [Read more...] about Nemera’s Safe’n’Spray wins Pharmapack 2020 innovation award
Koura announces clinical trial plans for Zephex 152a
Koura (formerly Mexichem Fluor) announced that the FDA has cleared the company's IND for Zephex HFA 152a MDI propellant, and the company plans to initiate clinical trials of the propellant this month. In December 2019, Chiesi announced that it intended to bring a Zephex 152a inhaler to market by the end of 2025. At DDL 2016, Koura presented data suggesting the … [Read more...] about Koura announces clinical trial plans for Zephex 152a
Hovione Technology announces the receipt of patent grants for its TwinMax DPI
According to Hovione Technology, the company has received patent grants for its TwinMax large dose DPI in a number of new territories. CEO Peter Villax said, “We achieved unchallenged patent grants for TwinMax in the United States, Europe, Japan, China and other territories. Our patented TwinMax will enable pharmaceutical partners to license them and to develop and … [Read more...] about Hovione Technology announces the receipt of patent grants for its TwinMax DPI
CapMedic inhaler sensor gets FDA clearance
Cognita Labs has received FDA clearance for its CapMedic digital inhaler sensor for use with metered dose inhalers, the company said. The CapMedic device, which fits over the top of the MDI actuator and includes a built in spirometer, provides audio and visual instruction to patients to encourage correct inhaler use. The device also connects to a smartphone app, … [Read more...] about CapMedic inhaler sensor gets FDA clearance
Merxin launches DPI for generic Ellipta products
UK-based device company Merxin has officially launched its new MRX006 multidose DPI, which has dual cavities and is designed specifically for triple therapies such as generic versions of Trelegy Ellipta. The company introduced the new DPI at DDL 2019 and reported that it fielded numerous inquiries about the device. In 2019, the FDA indicated that Merxin's MRX001 … [Read more...] about Merxin launches DPI for generic Ellipta products
Impopharma acquired by Rubicon Research
Canadian CRO Impopharma, which specializes in OINDP analysis and development, has been acquired by Rubicon Research, Rubicon said. Impopharma's Concord, ON facility will become Rubicon's Nasal and Pulmonary Center of Excellence. Impopharma's services included testing and development of nasal sprays, MDIs, and DPIs. According to Rubicon, the company expects the … [Read more...] about Impopharma acquired by Rubicon Research
Nanoform applies for GMP certification
Finnish nanonization specialists Nanoform have filed for GMP certification with the Finnish Medicines Agency (FIMEA), the company said. In December 2018, Nanoform announced construction of a new GMP manufacturing facility in Helsinki. The company, which recently won the the 2019 Excellence in Pharma: Formulation award at CPhI, plans to offer GMP clinical … [Read more...] about Nanoform applies for GMP certification